JAMA Network: Evaluating Progression of Depression Symptoms After Breast Cancer Diagnosis in Women

Editor May 31, 2022

 

Citation

Charles C, Bardet A, Larive A, et al. Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France. JAMA Netw Open. 2022;5(4):e225118. doi:10.1001/jamanetworkopen.2022.5118

Free access to the full-text article http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.5118?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=041422

Original Investigation
Oncology
April 14, 2022

Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France

Cécile Charles, PhD1,2; Aurélie Bardet, MS3,4; Alicia Larive, MS3,4; et al Philip Gorwood, MD, PhD5,6; Nicolas Ramoz, PhD5; Emilie Thomas, MS7; Alain Viari, PhD7; Marina Rousseau-Tsangaris, PhD7; Agnès Dumas, PhD8; Gwenn Menvielle, PhD8; Sibille Everhard, PhD9; Anne-Laure Martin, PhD9; Seyive-yvon-arnauld Gbenou10; Julie Havas, MS10; Mayssam El-Mouhebb, MS10; Antonio Di Meglio, MD, PhD10; Fabrice André, MD, PhD9; Barbara Pistilli, MD10; Charles Coutant, MD11; Paul Cottu, MD12; Asma Mérimèche, MD13; Florence Lerebours, MD14; Olivier Tredan, MD15; Laurence Vanlemmens, MD16; Christelle Jouannaud, MD17; Christelle Levy, MD18; Ines  Vaz-Luis, MD, PhD10; Stefan Michiels, PhD3,4; Sarah Dauchy, MD1
Author Affiliations Article Information
JAMA Netw Open. 2022;5(4):e225118. doi:10.1001/jamanetworkopen.2022.5118
Key PointsQuestion  Can distinct longitudinal patterns of depressive symptoms be characterized from diagnosis to 3 years after treatment for breast cancer?

Findings  In this cohort study of 4803 women with breast cancer, 6 trajectory groups that described the heterogeneity in the expression of depressive symptoms were identified. The trajectory groups with depressive symptoms differed from the noncases group (without depressive symptoms) by household income, previous psychiatric hospitalizations, obesity, moderate to high levels of fatigue, and depression at diagnosis.

Meaning  Findings of this study suggest that characterization of depressive trajectory groups after breast cancer diagnosis needs further validation but is a key step toward personalized management of patients at risk of depression, a common comorbidity in breast cancer associated with poorer prognosis.

Free access to the full-text article http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.5118?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=041422

SOURCE: This is an open access article distributed under the terms of the CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium. You are not required to obtain permission to reuse this article content, provided that you credit the author and journal; https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2791036?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=041422; https://media.jamanetwork.com/news-item/evaluating-progression-of-depression-symptoms-after-breast-cancer-diagnosis-in-women/

Editor

http://conciergemedicinetoday.org

Next Post

Event: Brazen BioTech Summit, June 12, 2022 in LA

Wed Jun 1 , 2022
“We help scientists become […]

You May Like